Qvintip® − BASED ON SWEDISH RESEARCH

Qvintip® has a solid clinical foundation and has been evaluated in partnership with the Cytological Laboratory, Akademiska hospital in Uppsala, Sweden. Collaboration with researchers remains one of our cornerstones. Currently, Qvintip has been studied in 25 clinical studies in total 90,000 women. Further clinical trials of 15,000 women are ongoing.

You find references to selected studies below.

• Wikström et al, Acta Obs et Gyn. 2007; 86 “Attitudes to self-sampling of vaginal smear for HPV analysis among women not attending organized cytological screening”

• Stenvall et al, Acta Derm Veneorol 2007; 87 “High prevalence of oncogenic HPV in women not attending organized cytological screening”

• Wikström et al, Acta Derm Veneorol 2007; 87 “Low prevalence of HR-HPV in older women not attending organized cytological screening: a pilot study”

• Stenvall H et al, Acta Obstetricia et Gynecologica. 2007; 86 “Accuracy of HPV testing of vaginal smear obtained with a novel self-sampling device”

• I Wikström et al. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. British Journal of Cancer 105, 337-339 (26 July 2011) | doi:10.1038/bjc.2011.236

• Gyllensten U et al. Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer. Br J Cancer 2011 Aug 23;105(5):694-7. doi: 10.1038/bjc.2011.277. Epub 2011 Aug 2